中国血液净化 ›› 2020, Vol. 19 ›› Issue (05): 334-337.doi: 10.3969/j.issn.1671-4091.2020.05.013

• 血管通路 • 上一篇    下一篇

尿激酶溶栓联合血管腔内成形术治疗人工血管动静脉内瘘早期血栓的效果分析

郜同心1,任建伟1   

  1. 1. 航空总医院肾内科
  • 收稿日期:2020-01-08 修回日期:2020-03-18 出版日期:2020-05-12 发布日期:2020-05-12
  • 通讯作者: 任建伟 rejane1988@126.com E-mail:gaotx521@163.com

The effects of thrombolysis using urokinase combined with percutaneous transluminal angioplasty in the treatment of acute thrombosis in arteriovenous graft

  1. 1Department of Nephrology, Aviation General Hospital, Beijing 100012, China
  • Received:2020-01-08 Revised:2020-03-18 Online:2020-05-12 Published:2020-05-12

摘要: 【摘要】目的探讨尿激酶局部溶栓联合血管腔内成形术治疗人工血管动静脉内瘘(arteriovenous graft,AVG)早期血栓形成的安全性及有效性。方法选取2017 年1 月~2018 年12 月20 位AVG 早期血栓患者作为研究对象,回顾性分析患者的临床资料,术前均通过血管超声明确AVG 血栓形成,使用尿激酶溶栓后使用注射器经血管鞘反复抽吸血栓,并使用高压球囊推挤残存血栓,并对内瘘狭窄处行球囊扩张,统计手术成功率、手术并发症、随访通畅率等。结果20 例手术取得成功,成功率100%;其中1 例穿刺点血肿,余病例无明显手术并发症。术后3 个月、6 个月及12 个月的初级通畅率分别为80.0%、70.0%、65.0%;次级通畅率分别为100%、100%、95%。结论尿激酶局部溶栓联合血管腔内成形术是治疗人工血管动静脉内瘘早期血栓形成的一种安全有效的方法。

关键词: 经皮腔内血管成形术, 人工血管动静脉内瘘, 早期血栓, 尿激酶

Abstract: 【Abstract】Objective To assess the safety and effectiveness of thrombolysis using urokinase combined with percutaneous transluminal angioplasty in the treatment of acute thrombosis in arteriovenous graft (AVG). Methods The clinical data of 20 patients with acute thrombosis in AVG and treated during the period from January 2017 to December 2018 were retrospectively analyzed. The diagnosis of acute thrombosis in AVG was confirmed by vascular ultrasound examination in all patients. After thrombolysis using urokinase, a syringe was used to repeatedly aspirate the thrombosis via the vascular sheath until no further thrombi could be aspirated, and angioplasty was then performed at the stenosis site as required. Technical success rate, complications and patency rate were analyzed. Results Technical success was achieved in all 20 cases (100 %). One case had hematoma at the puncture site, and the other cases had no complications. Primary patency rates were 100%, 87.5% and 75.0% after 3, 6, and 12 months, respectively. The secondary patency rates were 100%, 100% and 95%, respectively. Conclusions Thrombolysis using urokinase combined with percutaneous transluminal angioplasty in the treatment of acute thrombosis in AVG is safe and effective.

Key words: Percutaneous transluminal angioplasty, Arteriovenous graft, Acute thrombosis, Urokinase

中图分类号: